Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

University of Oxford spins off NightstaRx; raises £12mm through its Series A round

Executive Summary

The University of Oxford spun off biotech NightstaRx Ltd. to develop and market retinal dystrophy therapeutics. Concurrent with its formation, Syncona (a subsidiary of the Wellcome Trust) made a £12mm ($19.8mm) investment in NightstarRx's Series A round. Imperial Innovations (the technology transfer arm of Imperial College) also participated.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies